This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Sterile Active Pharmaceutical Ingredient Market

Sterile Active Pharmaceutical Ingredient Market

Sterile Active Pharmaceutical Ingredient Market By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines & Others), By Form, By Region - Global Market Insights 2019 to 2029

Sterile Active Pharmaceutical Ingredient Market
FACT1702MR
  • Mar-2022
  • List of Tables : 30
  • List of Figures : 58
  • 170 Pages
  • Healthcare

Growing Expenditure on Biopharmaceutical Production Driving Sterile Active Pharmaceutical Ingredients Market Growth

Introduction of new drugs for rare indications, rising prevalence of chronic diseases, and growing ageing population have increased the consumption of pharmaceuticals, which has boosted the pharmaceutical expenditure, globally.

According to OECD, Global spending on pharmaceuticals was US$ 1,120.6 Bn in 2015 and is expected to increase at a CAGR of 7.1% during 2016 - 2030. Various pharmaceutical and biotechnology companies are focusing on expanding their geographical footprint to increase pharmaceutical production capacity.

Global sterile active pharmaceutical ingredients market forecast by Fact.MR

For instance, in January 2019, Fujifilm announced plans to invest approximately US$ 90 Mn to boost its overall production capacity by expanding its production facility at North Carolina.

Growing pharmaceutical production and increasing pharmaceutical spending are expected to propel the growth of the global sterile active pharmaceutical ingredients market. By value, China held the largest share in 2018 accounting for ~79% of the market. By form, aqueous segment captured the largest share in terms of in 2029 and is projected to show an upward trend through 2029.

Avail customized purchase options for your needs

Rapid Shift from in-house Sterile Active Pharmaceutical Ingredients Production to Outsourced Production

Pharmaceutical companies are rapidly shifting from in-house manufacturing to outsourcing of manufacturing operations. North America shows balance in in-house to outsourcing production of sterile active pharmaceutical ingredients.

Approximately, 50% of the big pharmaceutical companies prefer in-house production of patented API and outsourcing of dosage form manufacturing. However, companies do not rely on sole producers but partner with various CMOs for manufacturing of finished dosage forms.

With a prolific rise in outsourcing of sterile active pharmaceutical ingredients, CMOs are expanding fill and finish capacity for sterile products. As can be evidenced in diagram below, North America on back of the aforementioned factors held a major chunk of market share in 2019, closely followed by South Asia which is also poised to exhibit a staggering growth of ~8% through 2029.

South Asia’s prolific growth can be attributed to presence of key API manufacturers in countries such as India. Additionally, the region will exhibit high growth on back of increased manufacturing of generic drugs.

Sterile active pharmaceutical ingredients market share analysis

Acquisition and Partnership Key Strategies in Sterile Active Pharmaceutical Ingredients Market

Manufacturers are focusing on expansion of product lines in the sterile active pharmaceutical ingredients segment owing to growing demand for parenteral drugs, biologics, and ophthalmic solutions. Key market stakeholders are adopting acquisition and merger strategies for expansion of production capabilities. For instance, in September 2018, Aurobindo Pharma USA Inc.

acquired commercial operations and three manufacturing facilities in the U.S from Sandoz Inc., USA. Also, manufactures are centering towards a strategic partnership with contract manufacturing organization and pharmaceutical companies to access advance manufacturing technologies for sterile products. In February 2017, Sanofi and Lonza entered a strategic partnership to operate large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.

An Adaptive Approach to Modern-day Research Needs

Increasing Research & Development Investments in Pharmaceutical Industry

The healthcare industry is heavily dependent on developing new treatment options for the treatment of various chronic diseases such as cancer, HIV, arthritis, cardiovascular diseases, etc. Increasing healthcare R&D expenditure, further improves the chances of possibility of breakthrough treatments.

As per the data from European Federation of Pharmaceutical Industries and Associations (EFPIA) and (Pharmaceutical Research and Manufacturers of America) PhRMA, annual pharmaceutical R&D expenditures expanded at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. during 2011-2016. Rapidly growing pharmaceutical expenditure is anticipated to result in new molecule discovery that favors the demand for sterile active pharmaceutical ingredients.

Key Segments of the Sterile Active Pharmaceutical Ingredients Market

Fact.MR’s study on the sterile active pharmaceutical ingredients market offers information divided into four important segments-product type, form and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

  • By Product Type :

    • Monoclonal Antibodies
    • Immunoglobulin
    • Cytokines
    • Insulin
    • Peptide Hormones
    • Blood Factors
    • Peptide Antibiotics
    • Vaccines
    • Small Molecule Antibiotics
    • Highly Potent Active Pharmaceutical Ingredients (HPAPI)
    • Others
  • By Form :

    • Aqueous
    • Non-Aqueous Liquid
    • Dry Powder
  • By Region :

    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • Middle East & Africa

- FAQs -

Growing Expenditure on Biopharmaceutical Production Driving Sterile Active Pharmaceutical Ingredients Market Growth
Sterile Active Pharmaceutical Ingredient Market is Expected to Grow at 7.1% CAGR

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Specialty Meat Ingredients Market

Specialty Meat Ingredients Market is poised to reach a valuation of US$ 5.2 billion by 2031. Fiber a...

Personal Care Active Ingredients Market

Personal Care Active Ingredients Market expects to grow at 5.7% CAGR by 2031. Personal Care Active I...

Cognitive Ingredients Market

Cognitive Ingredients Market to observe healthy growth by 2029. Rising demand for various memory enh...

Perfume Ingredient Chemicals Market

Perfume Ingredient Chemicals Market to grow at a CAGR of 5 % during the forecasted period 2019 to 20...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.